NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HemostOD SA

HemostOD SA

Private
Saint-SulpiceHealthcare & Life Scienceshttps://www.hemostod.com/

Last Round

Grant

Feb 3, 2026

Total Funding Raised

$10.64M

Company Overview

HemostOD SA is a biotechnology company that develops a proprietary platform for the ex vivo manufacturing of donor-free, universal human blood platelets for transfusion and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

platelet manufacturingex vivo blood plateletslab-grown bloodbioreactor platformuniversal plateletsCAR-PLTtargeted cargo deliverythrombocytopenia treatmentplatelet lysatesynthetic bloodstem cell engineeringtransfusion medicinebiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HemostOD SA Comps

Public and private peers based on sector, stage, and business model.

HemostOD SA comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HemostOD SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2026
SeedOct 1, 2025
DebtJun 11, 2024
DebtMay 3, 2022
SeedSep 7, 2021
Accelerator
Apr 29, 2021

Key People

Founding team and executive leadership

Faouzi Khechana

Co-Founder and CEO at HemostOD

Founding Team

Elodie Dahan

CTO

Executive Team

HemostOD SA Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 26, 2020

    $12K round from Venture Kick

HemostOD SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HemostOD SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HemostOD SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint-Sulpice
Employee Range10
Year Founded2020
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.